Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-25-015785
Filing Date
2025-09-26
Accepted
2025-09-26 17:16:29
Documents
17
Period of Report
2025-05-31

Document Format Files

Seq Description Document Type Size
1 10-K/A form10-ka.htm   iXBRL 10-K/A 332033
2 EX-4.2 ex4-2.htm EX-4.2 26363
3 EX-19.1 ex19-1.htm EX-19.1 47125
4 EX-31.3 ex31-3.htm EX-31.3 6410
5 EX-31.4 ex31-4.htm EX-31.4 7028
6 EX-97.1 ex97-1.htm EX-97.1 27967
  Complete submission text file 0001493152-25-015785.txt   754807

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bmra-20250531.xsd EX-101.SCH 11839
8 XBRL LABEL FILE bmra-20250531_lab.xml EX-101.LAB 60299
9 XBRL PRESENTATION FILE bmra-20250531_pre.xml EX-101.PRE 23521
19 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 9277
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-K/A | Act: 34 | File No.: 001-37863 | Film No.: 251351418
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)